Nerfasin 20 injection; Presence of particles
Last updated
Summary
Product
Nerfasin 20 mg/mL Injection
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot number |
|---|---|---|---|---|---|
Dechra Veterinary Products |
Nerfasin 20 mg/mL Injection |
DIN 02444089 |
Solution |
Xylazine hydrochloride 20 mg/mL |
20E091, 20G104, 20K212 |
Issue
Affected lot may contain the presence of particles.
What you should do
- Verify if your product is affected.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Similar recalls or alerts
Additional information
Background
Depth of recall: Veterinary clinics
Details
Original published date: 2023-05-15
Alert / recall type
Health product recall
Category
Health product - Veterinary drugs
Companies
Recalling firm:
Dechra Veterinary Products Inc.
1 Holiday Avenue East Tower Suite 345
Pointe-Claire Quebec H9R 5N3
Market Authorization Holder:
Dechra Regulatory B.V
Handelsweg 25
Bladel, Netherlands 5531 AE
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-73669